(Q57154016)

2

0 references

Mao-Lan Li

3

0 references

Qian Ding

4

0 references

Hao Weng

5

0 references

Wen-Guang Wu

6

0 references

Yang Cao

7

0 references

Run-Fa Bao

8

0 references

Yi-Jun Shu

9

0 references

Qi-Chen Ding

10

0 references

Jia-Sheng Mu

11

0 references

Jun Gu

12

0 references

Ping Dong

13

0 references

Ying-Bin Liu

Annals of Surgical Oncology

14

0 references

language of work or name

English

0 references

publication date

February 2014

0 references

published in

0 references

volume

21

0 references

issue

2

0 references

page(s)

449-57

0 references

cites work

Surgery for gallbladder cancer: a population-based analysis

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Identification of metastasis-associated proteins involved in gallbladder carcinoma metastasis by proteomic analysis and functional exploration of chloride intracellular channel 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Reactive oxygen species-mediated endoplasmic reticulum stress and mitochondrial dysfunction contribute to cirsimaritin-induced apoptosis in human gallbladder carcinoma GBC-SD cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Wogonin, an active ingredient of Chinese herb medicine Scutellaria baicalensis, inhibits the mobility and invasion of human gallbladder carcinoma GBC-SD cells by inducing the expression of maspin

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

NLK is a key regulator of proliferation and migration in gallbladder carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Gallbladder cancer in India: a dismal picture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Long-term results after resection for gallbladder cancer. Implications for staging and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Outcomes and prognostic factors in gallbladder cancer: a single-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Invasion of the hepatic artery is a crucial predictor of poor outcomes in gallbladder carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Chemokine (C-X-C motif) ligand 12 is associated with gallbladder carcinoma progression and is a novel independent poor prognostic factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Analysis of the relationships between clinicopathologic factors and survival in gallbladder cancer following surgical resection with curative intent

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Prognostic factors in patients with gallbladder cancer after surgical resection: analysis of 279 operated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Carcinoma of the gallbladder. Staging, treatment, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Inflammation-based prognostic system predicts survival after surgery for stage IV colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Initial neutrophil lymphocyte ratio is superior to platelet lymphocyte ratio as an adverse prognostic and predictive factor in metastatic colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Pretreatment neutrophil/lymphocyte ratio is superior to platelet/lymphocyte ratio as a predictor of long-term mortality in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Prognostic value of jaundice in patients with gallbladder cancer by the AFC-GBC-2009 study group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

High blood neutrophil-to-lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Three-step method for lymphadenectomy in gastric cancer surgery: a single institution experience of 120 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

21 January 2018

Inflammation and cancer

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Improving the accuracy of pre-operative survival prediction in renal cell carcinoma with C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Inflammation-based prognostic score, prior to neoadjuvant chemoradiotherapy, predicts postoperative outcome in patients with esophageal squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Tumor-associated neutrophils: new targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

The immunobiology of cancer immunosurveillance and immunoediting

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Cancer regression in patients after transfer of genetically engineered lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z

Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-013-3292-Z